Strategies & Tactics for Clinical Research Project Management

A clinical trial project manager (CTPM) is the nucleus of a clinical trial, therefore the success of each trial is heavily dependent on the performance of the CTPM.  This recent article, 7 Breakthrough Behaviors For Clinical Research Project Managers, presents easy-to-implement strategies and tactics that will help CTPMs – and their organizations – achieve consistent[…]

FDA’s View on Postmarket Drug Safety

FDA and Medscape series for healthcare professionals The interview features Gerald Dal Pan, MD, MHS, Director, Office of Surveillance and Epidemiology, FDA Center for Drug Evaluation and Research FDA. Dr. Pan responds to questions from Medscape to detail the FDA’s outlook on postmarket drug safety. The article is part of a collaboration between FDA and[…]

FDA Publicizes Strategic Plan to Clear Bottleneck of Orphan Designation Requests

The FDA has about 200 orphan drug designation requests that are pending review and that number has been steadily rising over the past five years. Recently, the FDA publicized its strategic plan to clear the bottleneck as part of its strategic plan to eliminate the agency’s existing orphan designation request backlog and ensure continued timely[…]